PAHC logo

PAHC
Phibro Animal Health Corp. - Ordinary Shares - Class A

288
Mkt Cap
$1.36B
Volume
113,932.00
52W High
$60.08
52W Low
$22.51
PE Ratio
14.37
PAHC Fundamentals
Price
$33.72
Prev Close
$33.46
Open
$33.98
50D MA
$50.71
Beta
1.15
Avg. Volume
262,268.15
EPS (Annual)
$1.19
P/B
3.75
Rev/Employee
$523,723.23
$1,723.43
Loading...
Loading...
News
all
press releases
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address...
News Placeholder
More News
News Placeholder
Reasons to Add Align Technology Stock to Your Portfolio Now
ALGN expands Invisalign worldwide and iTero Lumina leads scanner mix, backed by $1.06B cash, yet 2026 ASP expected down 1-2%.
News Placeholder
AUNA Q1 Earnings Miss, Revenues Beat, Margins Contract, Stock Dips
Auna's Q1 2026 EPS misses expectations as margins tighten despite 18.7% revenue growth; shares fall 2.7% in after-hours trading.
News Placeholder
Is This the Right Time to Retain ILMN Stock in Your Portfolio?
Illumina advances its sequencing strategy with strong NovaSeq X momentum and clinical demand, but China's weakness and macro pressures cloud the outlook.
News Placeholder
Is This the Right Time to Hold DGX Stock in Your Portfolio?
Quest Diagnostics gains from DIS growth, advanced diagnostics uptake and AI-driven efficiencies, though debt levels and healthcare reimbursement risks remain concerns.
News Placeholder
PAHC or SYK: Which Is the Better Value Stock Right Now?
PAHC vs. SYK: Which Stock Is the Better Value Option?
News Placeholder
EYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands
National Vision beats EPS and revenue estimates as comps rise 4.5% and operating margin jumps 320 bps; 2026 guidance reiterated.
News Placeholder
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
Prestige Consumer misses Q4 EPS and revenue estimates as Clear Eyes supply limits and Middle East shipping disruptions pressure sales and margins.
News Placeholder
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
News Placeholder
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available